210 related articles for article (PubMed ID: 429556)
1. Decreased heat-labile opsonic activity and complement levels associated with evidence of C3 breakdown products in infected pleural effusions.
Lew PD; Zubler R; Vaudaux P; Farquet JJ; Waldvogel FA; Lambert PH
J Clin Invest; 1979 Feb; 63(2):326-34. PubMed ID: 429556
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of a local exhaustion of complement components and of an enzymatic degradation of immunoglobulins in pleural empyema: a possible factor favouring the persistence of local bacterial infections.
Lew DP; Despont JP; Perrin LH; Aguado MT; Lambert PH; Waldvogel FA
Clin Exp Immunol; 1980 Dec; 42(3):506-14. PubMed ID: 6908546
[TBL] [Abstract][Full Text] [Related]
3. [Activation of the alternative complement pathway in pleural fluid of patients with pneumonia].
Aguado MT; Celada A
Allergol Immunopathol (Madr); 1982; 10(3):215-20. PubMed ID: 6924537
[TBL] [Abstract][Full Text] [Related]
4. [Immunologic study of pleural neoplastic effusions: Detection of immune complexes and complement activation].
Kaelin R; Docquier C; Lew D; Carpentier N; Lambert PH; Waldvogel FA
Schweiz Med Wochenschr; 1978 Dec; 108(49):1971-3. PubMed ID: 749195
[TBL] [Abstract][Full Text] [Related]
5. High levels of complement breakdown products in tuberculous pleural effusions.
Lew DP; Perrin LH; Vassalli JD; Suter S; Lambert PH; Waldvogel FA
Clin Exp Immunol; 1983 Jun; 52(3):569-74. PubMed ID: 6603298
[TBL] [Abstract][Full Text] [Related]
6. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of complement components in pleural fluid: report of 135 cases.
Shitrit D; Ollech JE; Ollech A; Peled N; Amital A; Fox B; Kramer MR
Respir Med; 2008 Nov; 102(11):1631-5. PubMed ID: 18653322
[TBL] [Abstract][Full Text] [Related]
8. Pleural fluid complement, complement conversion, and immune complexes in immunologic and nonimmunologic diseases.
Hunder GG; McDuffie FC; Huston KA; Elveback LR; Hepper NG
J Lab Clin Med; 1977 Dec; 90(6):971-80. PubMed ID: 597373
[TBL] [Abstract][Full Text] [Related]
9. Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions.
Castaño Vidriales JL; Amores Antequera C
Eur J Med; 1992; 1(4):201-7. PubMed ID: 1341445
[TBL] [Abstract][Full Text] [Related]
10. Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients.
Teshima H; Wanebo H; Pinsky C; Day NK
J Clin Invest; 1977 Jun; 59(6):1134-42. PubMed ID: 325016
[TBL] [Abstract][Full Text] [Related]
11. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
[TBL] [Abstract][Full Text] [Related]
12. Loculated pleural empyema: identification of complement breakdown products in contiguous sterile pleural fluid.
Lew PD; Perrin LH; Waldvogel FA; Lambert PH
Scand J Infect Dis; 1982; 14(3):225-9. PubMed ID: 6924409
[TBL] [Abstract][Full Text] [Related]
13. The effect of C3 levels on yeast opsonization by normal and pathological sera: identification of a complement independent opsonin.
Kerr MA; Falconer JS; Bashey A; Beck JS
Clin Exp Immunol; 1983 Dec; 54(3):793-800. PubMed ID: 6652976
[TBL] [Abstract][Full Text] [Related]
14. Complement in BuB/BnJ mice revisited: serum C3 levels and complement opsonic activity are not elevated.
Osmers I; Szalai AJ; Tenner AJ; Barnum SR
Mol Immunol; 2006 Apr; 43(10):1722-5. PubMed ID: 16310250
[TBL] [Abstract][Full Text] [Related]
15. Recruitment of inflammatory cells to the pleural space. Chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids.
Antony VB; Godbey SW; Kunkel SL; Hott JW; Hartman DL; Burdick MD; Strieter RM
J Immunol; 1993 Dec; 151(12):7216-23. PubMed ID: 8258721
[TBL] [Abstract][Full Text] [Related]
16. Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease.
Liu CL; Hsieh WY; Wu CL; Kuo HT; Lu YT
Respir Med; 2007 May; 101(5):903-9. PubMed ID: 17097866
[TBL] [Abstract][Full Text] [Related]
17. Rapid diagnosis of infectious pleural effusions by use of reagent strips.
Azoulay E; Fartoukh M; Galliot R; Baud F; Simonneau G; Le Gall JR; Schlemmer B; Chevret S
Clin Infect Dis; 2000 Oct; 31(4):914-9. PubMed ID: 11049770
[TBL] [Abstract][Full Text] [Related]
18. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
Håkansson L; Hällgren R; Venge P
Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
[TBL] [Abstract][Full Text] [Related]
19. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of C3 and IgG proteolysis enhances phagocytosis of Porphyromonas gingivalis.
Cutler CW; Arnold RR; Schenkein HA
J Immunol; 1993 Dec; 151(12):7016-29. PubMed ID: 8258706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
